- (2025). Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial. Lancet 405, 2129-2143. CNIO Publication.
- (2025). Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials. Lancet 404, 2584-2592. CNIO Publication.
Open Access
- (2025). Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy. New Engl J Med (in press). CNIO Publication.
- (2025). Cell cycle duration determines oncogenic transformation capacity. Nature 641, 1309-1318. CNIO Publication.
- (2025). Geographic and age variations in mutational processes in colorectal cancer. Nature (in press). CNIO Publication.
- (2025). Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses. Nature 640, 524-533. CNIO Publication.
- (2025). Macrophages harness hepatocyte glutamate to boost liver regeneration. Nature 641, 1005-1016. CNIO Publication.
- (2025). Integrating priorities at the intersection of cancer and neuroscience. Cancer Cell 43, 1-5. CNIO Publication.
- (2025). Inherited genome instability. Science 387, 26-27. CNIO Publication.